What the Humira Biosimilar Shift Means for Patient Care
Humira changed treatment for many autoimmune diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. But it also became a symbol of how hard biologic medicines can be to access. Now that several adalimumab biosimilars are on the market, the central question is no longer whether alternatives exist. It is which differences matter, which do […]
What the Humira Biosimilar Shift Means for Patient Care Read More »









